First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults

Title
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults
Authors
Keywords
Tuberculosis, Vaccine, H56, Latent, Clinical trial
Journal
VACCINE
Volume 33, Issue 33, Pages 4130-4140
Publisher
Elsevier BV
Online
2015-06-19
DOI
10.1016/j.vaccine.2015.06.051

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started